1Greenhill LL, Pliszka S, Dulcan MK, et al. Practice parameter for the use of stimulant medications in the treatment of children,adolescents, and adults. J Am Acad Child Adolesc Psychiatry,2002, 41 Suppl 2:26S-49S.
2Spencer T, Biederman J, Wilens T, et al. Efficacy of a mixed amphetamine salts compound in adults with attentlon-deficit/hyperactivity disorder. Arch Gen Psychiatry, 2001, 58:775-782.
3Reeves G, Schweitzer J. Pharmacological management of attention-deficit hyperactivity disorder. Expert Opin Pharmacother, 2004, 5 :1313-1320.
4Wilens TE, Spencer TJ, Biederman J. A review of the pharmacothempy of adults with attention-deficlt/hyperactivity disorder. J Atten Disord, 2002, 5:189-202.
5Rochdi M, Gonzalez MA, Dirksen SJ. Dose-proportional pharmacokinetics of a methylphenidate extended-release capsule. Int J Clin Pharmacol Ther, 2004, 42:285-292.
6Faraone SV, Biederman J. Efficacy of adderall for attention-deficit/hyperactivity disorder: a meta-analysis. J Atten Disord, 2002,6:69-75.
7Wolraich ML, Greenhill LL, Pelham W, et al. Randomized,controlled trial of oros melhylphenidate once a day in children with attention-deficit/hyperactivity disorder. Pediatrics, 2001, 108 : 883-892.
8Levin ED, Rezvani AH. Nicotinic treatment for cognitive dysfunction. Curr Drug Targets CNS Neurol Disord, 2002, 1:423-431.
9Levin ED, Rezvani AH. Development of nicotinic drug therapy for cognitive disorders. Eur J Phannacol, 2000, 393 : 141-146.
10Levin ED, Conners CK, Sparrow E, et al. Nicotine effects on adultswith attention-deficit/hyperactivity disorder. Psychopharmacology(Berl), 1996, 123:55-63.
同被引文献3
1Wender PH,Wolf LE,Wasserstein.Adults with ADHD.An overview.Ann N Y Acad Sci,2001,931:1-6
2Schubiner H,Tzelepis A,et al.Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers.Clin Psychiatry,2000,61:244-251
3M.G.Gelder et al.New Oxford textbook of psychiatry volume 2:1736-1737
